Clinical trial NCT05721092: Assessment of Knowledge on Pneumococcal Vaccination Among Diabetologists in India
Official title: Assessment of Knowledge, Facilitators and Barriers of Pneumococcal Vaccination: A Cross-sectional Study Among Diabetologists in India
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Pneumococcal Vaccine
Lead sponsor: M.V. Hospital for Diabetes
Sponsor class: OTHER
Collaborators: name: MSD Pharmaceuticals LLC
First posted: 2023-02-09
Enrollment: 100
Sex: ALL
Minimum age (years): 25
Maximum age (years): 65
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Observational model: COHORT
Time perspective: CROSS_SECTIONAL
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Diabetologists aged 25 to 65, practicing in India

Brief summary: Asia has the highest burden with the largest contribution of pneumonia burden from India. Pneumonia is also observed as 5th leading cause of deaths in India. People with diabetes with uncontrolled glucose are significantly at higher risk of development of pneumonia. Even though, pneumonia is a vaccine-preventable disease, hospitalization for pneumonia of patients with diabetes are rising. Very limited literature is available on the knowledge and practice of pneumonia vaccination among diabetologists and the rate of pneumonia vaccination received by the patients with diabetes. Hence this study aims to assess their knowledge on the same. In addition, this study also aims to identify the real barriers and facilitators of pneumococcal vaccination among diabetologists in India. A cross-sectional study will be conducted among 25diabetologists in each of the four zones in India representing all directions - North, East, West and South. Diabetologists will be selected through purposive sampling. A semi-structured questionnaire (study tool) is designed based on the existing literature that addresses our objectives. An education session on Pneumococcal vaccination will be conducted for the diabetologists through webinar after completing the survey. A post assessment will be done using the same questionnaire among the study participants after the education session in order to see an increase in the knowledge of pneumococcal vaccination.


Eligibility criteria: Inclusion Criteria:

Diabetologists willing to participate in the study

Exclusion Criteria:

Unwillingness to give consent for participation

Primary outcomes:
measure: To identify the facilitators and barriers of pneumococcal vaccination among diabetologists in India.
timeFrame: 6 months
Secondary outcomes:
measure: To assess the knowledge, attitude and practices of pneumococcal vaccination among select diabetologists across India.
timeFrame: 6 months
measure: To examine the association of knowledge and practice of vaccination among diabetologists
timeFrame: 6 months
measure: To assess the change in the knowledge of pneumococcal vaccination post educational intervention
timeFrame: 6 months
Other outcomes:
Locations:
city: Chennai
country: India
facility: M V Hospital for Diabetes [P] Limited
state: Tamil Nadu
Study officials:
affiliation: M V Hospital for Diabetes [P] Limited
name: Vijay Viswanathan
role: PRINCIPAL_INVESTIGATOR
References: